During the past decade, Tennessee Clinical Research Center conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 39 clinical trials were completed, i.e. on average, 78% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 23 clinical trials were completed. i.e. 164.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tennessee Clinical Research Center" #1 sponsor was "Galderma R&D" with 8 trials, followed by "Stiefel, a GSK Company" with 5 trials sponsored, "Prollenium Medical Technologies Inc." with 4 trials sponsored, "DUSA Pharmaceuticals, Inc." with 3 trials sponsored and "Maruho Co., Ltd." with 3 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Clinical Research Center" #1 collaborator was "GlaxoSmithKline" with 4 trials as a collaborator, "Symbio, LLC" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Prosoft Clinical" with 2 trials as a collaborator and "Astellas Pharma Europe B.V." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Clinical Research Center" are "Acne Vulgaris" (11 trials), "Onychomycosis" (6 trials), "Psoriasis" (6 trials), "Actinic Keratosis" (5 trials) and "Atopic Dermatitis" (4 trials). Many other conditions were trialed in "Tennessee Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Tennessee Clinical Research Center" are "Drug" (69 trials), "Device" (21 trials), "Biological" (6 trials), "Other" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Vehicle" (6 trials), "LIPO-202" (3 trials), "PN40082" (3 trials) and "S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Clinical Research Center" are 88 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Tennessee Clinical Research Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Tennessee Clinical Research Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Clinical Research Center, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".